PATENT CLAIM ANALYSIS

Application Number: 15771775
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["540", "575000"]

Abstract:
The present invention relates to a compound represented by Chemical Formula, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of sodium channel blocker-related diseases.

Claim (Index 7):
The compound or pharmaceutically acceptable salt thereof according to  claim 1 , wherein R 5 , R 6 , and R 5  and R 6  together with the nitrogen to which they are attached form any one selected from the group consisting of the following:

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.28125
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16061815', '16086654', '14435473', '13707096', '11728897']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533752989872935
- 35 USC 102 Novelty (BERT): 0.5689641213598065
- Combined Prediction Score: 0.7349341812245448
- Mean Citation Score: 414.399758
- Max Citation Score: 452.23602
- Similarity Product: 356.07309748164283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test